DIA 2017 Editor’s Take – Medpace

Thought Leader:

Richard Scheyer, M.D. Vice President, Medical Affairs, Medpace

July 28, 2017      

Richard Scheyer discusses the importance of patient-centricity in rare disease studies, the benefits of customized studies, connecting with key investigators, and the increased interest in rare diseases.

For more information please visit www.medpace.com/.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK